Stock LLY ELI LILLY AND COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Eli Lilly and Company

Equities

LLY

US5324571083

Real-time Estimate Cboe BZX
Other stock markets
 12:40:51 2024-06-10 pm EDT 		5-day change 1st Jan Change
859.4 USD +1.11% Intraday chart for Eli Lilly and Company +3.53% +47.63%
01:00pm US FDA advisers to review Eli Lilly Alzheimer's drug RE
12:55pm Eli Lilly Study Shows Tirzepatide Superior to Placebo MT

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
US FDA advisers to review Eli Lilly Alzheimer's drug
RE
Eli Lilly Study Shows Tirzepatide Superior to Placebo
MT
Added health benefits of Wegovy, Zepbound could attract more men, doctors say
RE
Eli Lilly: promising trial for tirzepatide in MASH
CF
US FDA Staff Flags Potential Limited Benefit of Eli Lilly's Alzheimer's Disease Drug
MT
US FDA panel to vote on data, risk profile of Lilly Alzheimer's drug
RE
Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China
RE
Health Care Climbs on Obesity-Drug Bets - Health Care Roundup
DJ
UK Stocks-Factors to watch on June 6
RE
UK Institute Makes Draft Recommendation for Eli Lilly's Weight-loss Drug With No Time Limit
MT
Britain considers offering Lilly weight-loss drug on better terms than Wegovy
RE
Eli Lilly: encouraging data for olomorasib
CF
Structure Therapeutics' obesity drug meets main goal in mid-stage study
RE
Eli Lilly and Company Announces Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors Presented at the 2024 ASCO® Annual Meeting
CI
Danish Government Implements Stricter Subsidy Rules for Diabetes Drugs
MT
Wegovy maker Novo Nordisk sues nine spas, clinics and pharmacies over copycat drugs
RE
Eli Lilly's Retevmo Gets FDA Accelerated Approval for Kids With RET-altered Thyroid Cancer, Solid Tumors
MT
Eli Lilly: donates $6.5 million to UNICEF fund
CF
Annual sales of weight-loss drugs seen hitting $150 billion
RE
Weight-loss drug forecasts jump to $150 billion as supply grows
RE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LLY Stock
  4. News Eli Lilly and Company
  5. Highlights